Home Cart 0 Sign in  
X

[ CAS No. 1448-87-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1448-87-9
Chemical Structure| 1448-87-9
Chemical Structure| 1448-87-9
Structure of 1448-87-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1448-87-9 ]

Related Doc. of [ 1448-87-9 ]

Alternatived Products of [ 1448-87-9 ]

Product Details of [ 1448-87-9 ]

CAS No. :1448-87-9 MDL No. :MFCD00043907
Formula : C8H5ClN2 Boiling Point : -
Linear Structure Formula :- InChI Key :BYHVGQHIAFURIL-UHFFFAOYSA-N
M.W : 164.59 Pubchem ID :238938
Synonyms :

Calculated chemistry of [ 1448-87-9 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 44.55
TPSA : 25.78 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.72 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.9
Log Po/w (XLOGP3) : 2.23
Log Po/w (WLOGP) : 2.28
Log Po/w (MLOGP) : 1.45
Log Po/w (SILICOS-IT) : 2.62
Consensus Log Po/w : 2.1

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.94
Solubility : 0.19 mg/ml ; 0.00115 mol/l
Class : Soluble
Log S (Ali) : -2.41
Solubility : 0.645 mg/ml ; 0.00392 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.94
Solubility : 0.0191 mg/ml ; 0.000116 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.69

Safety of [ 1448-87-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1448-87-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1448-87-9 ]
  • Downstream synthetic route of [ 1448-87-9 ]

[ 1448-87-9 ] Synthesis Path-Upstream   1~28

  • 1
  • [ 1448-87-9 ]
  • [ 5424-05-5 ]
YieldReaction ConditionsOperation in experiment
5% With ammonia In methanol; hexane; dichloromethane Step 1:
To 2-chloroquinoxaline (1.0 g, 6 mmol) was added ammonia in methanol (8 mL of a 2M solution).
The reaction was sealed in a vial, heated to 80° C., and stirred for 12 hours.
The reaction was cooled to room temperature and concentrated under reduced pressure.
The residue was taken up in methylene chloride and filtered.
Hexane was added until a precipitate formed which was filtered and found to be the desired product (5percent yield).
Reference: [1] Angewandte Chemie - International Edition, 2015, vol. 54, # 12, p. 3773 - 3777[2] Angew. Chem., 2015, vol. 127, # 12, p. 3844 - 3848,5
[3] Organic Letters, 2013, vol. 15, # 14, p. 3734 - 3737
[4] Tetrahedron, 2010, vol. 66, # 34, p. 6958 - 6964
[5] Patent: US2003/69284, 2003, A1,
[6] Journal of the Chemical Society, 1945, p. 622,625
[7] Patent: US2537870, 1946, ,
  • 2
  • [ 1196-57-2 ]
  • [ 1448-87-9 ]
YieldReaction ConditionsOperation in experiment
93% With trichlorophosphate In toluene for 1 h; Reflux The chlorination of the 2-hydroxy quinoxaline was carried out in neat POCl3 (2.3 eqs) at reflux for an hour and produced the 2-chloro-quinoxaline (1D-008) in very good yield. This chemistry was tested on 100 g scale and afforded typically 103-105 g (98-99percent). A quick filtration through a Pad of silica of the crude reaction mixture resulted in clean material (99percent pure by LCMS). This reaction has beenscaled up to 600 g.
Reference: [1] Patent: US2017/143706, 2017, A1, . Location in patent: Paragraph 0050; 0106; 0107
[2] Helvetica Chimica Acta, 2001, vol. 84, # 5, p. 1112 - 1118
[3] Heterocycles, 2005, vol. 65, # 1, p. 181 - 185
[4] Heterocycles, 2006, vol. 68, # 9, p. 1973 - 1979
[5] Journal of the Chemical Society, 1945, p. 622,625
[6] Journal of the Chemical Society, 1957, p. 3236,3237
[7] Bulletin de la Societe Chimique de France, 1959, p. 1793,1796
[8] Patent: US2537870, 1946, ,
[9] Heterocycles, 1985, vol. 23, # 10, p. 2603 - 2611
[10] Chemistry Letters, 1984, p. 323 - 326
[11] Heterocycles, 2012, vol. 86, # 2, p. 1583 - 1590
  • 3
  • [ 1196-57-2 ]
  • [ 1448-87-9 ]
YieldReaction ConditionsOperation in experiment
81% at 110℃; for 12 h; Inert atmosphere The 2.000g2-hydroxy quinoxaline in 20mL phenylphosphonic dichloride, under nitrogen conditions, 110 ° C reflux 12h. The reaction was monitored by TLC. After completion of the reaction, the reaction solution was cooled to room temperature, poured into ice water slowly with constant stirring. product After precipitation, filtration, washing, drying, you can get 1.830g2- chloro quinoxaline (intermediate II-1), a yield of 81percent.
75% for 2 h; Reflux Place 2-hydroxyquinoxaline (2 g) and phosphorus oxychloride (20 mL) in 100 mLIn a three-neck flask, add 5 drops of DMF, and transfer the system to reflux for 2h.In a 500 mL beaker, add an appropriate amount of ice water. White solids precipitated,Yield 75percent.
75% for 2 h; Reflux 2-hydroxyquinoxaline (2 g) and phosphorus oxychloride (20 mL) were placed in 100 mL of threeStir in the bottle, add 5 drops of DMF, reflux for 2 h, transfer the system to a 500 mL beaker, and add an appropriate amount of ice water. Precipitating whiteSolid, yield 75percent
35% at 79 - 100℃; for 0.25 h; General procedure: 0.13 mL of N,N-dimethylformamide was added dropwise to a slurry monohydroxy quinoxaline 1d-e (0.5g, 3.1 mmol) and thionyl chloride (0.73 g, 6.2 mmol) in 1-chlorobutane(5 mL). The resulting reaction mixture was refluxed for 15min., and then evaporated to dryness under reduced pressure to leave a solid. The residue was taken up in a minimum of CH2Cl2, filtered and washed with CH2Cl2. Concentration then give the halogenated derivatives.

Reference: [1] Molecules, 2012, vol. 17, # 4, p. 4533 - 4544
[2] ChemMedChem, 2015, vol. 10, # 1, p. 193 - 206
[3] Patent: CN103787992, 2016, B, . Location in patent: Paragraph 0079-0082
[4] Patent: CN107602539, 2018, A, . Location in patent: Paragraph 0043
[5] Patent: CN108530435, 2018, A, . Location in patent: Paragraph 0015; 0017
[6] Tetrahedron Letters, 1999, vol. 40, # 42, p. 7477 - 7478
[7] Synthetic Communications, 2005, vol. 35, # 15, p. 1983 - 1987
[8] Synthetic Communications, 2011, vol. 41, # 23, p. 3532 - 3540
[9] Chemistry - A European Journal, 2009, vol. 15, # 19, p. 4857 - 4864
[10] Journal of Medicinal Chemistry, 2011, vol. 54, # 13, p. 4508 - 4522
[11] Revue Roumaine de Chimie, 2017, vol. 62, # 12, p. 903 - 906
[12] Journal of Physical Organic Chemistry, 1994, vol. 7, # 10, p. 545 - 550
[13] Journal of Organic Chemistry, 2003, vol. 68, # 5, p. 2054 - 2057
[14] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 24, p. 6723 - 6728
[15] Patent: US4076806, 1978, A,
[16] Medicinal Chemistry Research, 2013, vol. 22, # 4, p. 1660 - 1673
  • 4
  • [ 6935-29-1 ]
  • [ 1448-87-9 ]
YieldReaction ConditionsOperation in experiment
63% With N,N-dimethyl-formamide; trichlorophosphate In dichloromethane at 0 - 25℃; Inert atmosphere General procedure: The procedure is identical to general procedure I, except that reactions were conducted at 0.2 M concentration with N-oxide (1.00 equiv), POBr3 (3.00 equiv), DMF (1.50 equiv) at rt. 4.2 General procedure I for the bromination of azine N-oxides (0013) To a stirred solution of the appropriate azine N-oxides in anhydrous CH2Cl2 (0.1 M) at 0 °C is added POBr3 (1.2 equiv) followed by dropwise addition of DMF (0.5 equiv) under argon. The resulting reaction mixture was warmed to 25 °C and stirred for several hours until the reaction is complete as indicated by TLC. Saturated aqueous sodium carbonate solution is added to the reaction mixture slowly to adjust the pH to 7–8. The resulting mixture is separated and the aqueous phase is extracted with CH2Cl2 thoroughly. The organic phase is combined and washed with brine, dried over Na2SO4, filtered and concentrated under reduced pressure to afford the crude product, which is purified by flash column chromatography using PE/EA (100:1) as eluent.
Reference: [1] Tetrahedron, 2016, vol. 72, # 38, p. 5762 - 5768
[2] Journal of the Chemical Society, 1953, p. 2816,2819
  • 5
  • [ 5227-59-8 ]
  • [ 1448-87-9 ]
Reference: [1] Tetrahedron Letters, 2010, vol. 51, # 42, p. 5516 - 5520
  • 6
  • [ 95-54-5 ]
  • [ 1448-87-9 ]
Reference: [1] Journal of Physical Organic Chemistry, 1994, vol. 7, # 10, p. 545 - 550
[2] Journal of the Chemical Society, 1945, p. 622,625
[3] Bulletin de la Societe Chimique de France, 1959, p. 1793,1796
[4] Patent: US2537870, 1946, ,
[5] Journal of the Chemical Society, 1957, p. 3236,3237
[6] Journal of the Chemical Society, 1945, p. 622,625
[7] Medicinal Chemistry Research, 2013, vol. 22, # 4, p. 1660 - 1673
  • 7
  • [ 1196-57-2 ]
  • [ 1448-87-9 ]
  • [ 877078-00-7 ]
Reference: [1] Phosphorus, Sulfur and Silicon and the Related Elements, 2005, vol. 180, # 8, p. 1795 - 1807
  • 8
  • [ 51-17-2 ]
  • [ 67-66-3 ]
  • [ 1448-87-9 ]
  • [ 91-15-6 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1980, # 12, p. 4935 - 4953
  • 9
  • [ 61645-34-9 ]
  • [ 1448-87-9 ]
  • [ 1196-57-2 ]
Reference: [1] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1983, p. 217 - 220[2] Khimiya Geterotsiklicheskikh Soedinenii, 1983, vol. 19, # 2, p. 265 - 267
  • 10
  • [ 120569-15-5 ]
  • [ 1448-87-9 ]
  • [ 119-61-9 ]
  • [ 67-72-1 ]
  • [ 983-79-9 ]
Reference: [1] Tetrahedron Letters, 1988, vol. 29, # 48, p. 6287 - 6290
  • 11
  • [ 18671-97-1 ]
  • [ 1448-87-9 ]
Reference: [1] Heterocycles, 1987, vol. 26, # 5, p. 1215 - 1220
  • 12
  • [ 20254-76-6 ]
  • [ 1448-87-9 ]
Reference: [1] Journal of the Chemical Society, 1945, p. 622,625
  • 13
  • [ 2427-71-6 ]
  • [ 1448-87-9 ]
  • [ 18671-97-1 ]
Reference: [1] Chemistry Letters, 1984, p. 323 - 326
  • 14
  • [ 6935-29-1 ]
  • [ 91-19-0 ]
  • [ 1448-87-9 ]
  • [ 5448-43-1 ]
  • [ 7483-33-2 ]
Reference: [1] Tetrahedron, 1989, vol. 45, # 24, p. 7795 - 7804
  • 15
  • [ 6935-29-1 ]
  • [ 1448-87-9 ]
  • [ 5448-43-1 ]
  • [ 62163-09-1 ]
  • [ 1196-57-2 ]
Reference: [1] Tetrahedron, 1989, vol. 45, # 24, p. 7795 - 7804
  • 16
  • [ 59564-59-9 ]
  • [ 1448-87-9 ]
Reference: [1] Journal of Physical Organic Chemistry, 1994, vol. 7, # 10, p. 545 - 550
  • 17
  • [ 91-19-0 ]
  • [ 1448-87-9 ]
Reference: [1] Journal of the Chemical Society, 1953, p. 2816,2819
  • 18
  • [ 23395-75-7 ]
  • [ 1448-87-9 ]
Reference: [1] Journal of the Chemical Society, 1945, p. 622,625
  • 19
  • [ 49679-45-0 ]
  • [ 1448-87-9 ]
Reference: [1] Journal of the Chemical Society, 1945, p. 622,625
  • 20
  • [ 36818-07-2 ]
  • [ 1448-87-9 ]
Reference: [1] Journal of the Chemical Society, 1945, p. 622,625
  • 21
  • [ 6935-29-1 ]
  • [ 1448-87-9 ]
  • [ 5448-43-1 ]
Reference: [1] Bulletin des Societes Chimiques Belges, 1986, vol. 95, # 8, p. 663 - 670
  • 22
  • [ 6935-29-1 ]
  • [ 7677-24-9 ]
  • [ 91-19-0 ]
  • [ 1448-87-9 ]
  • [ 23088-24-6 ]
  • [ 77130-32-6 ]
  • [ 1196-57-2 ]
  • [ 7483-33-2 ]
Reference: [1] Tetrahedron, 1989, vol. 45, # 24, p. 7795 - 7804
  • 23
  • [ 6935-29-1 ]
  • [ 10025-87-3 ]
  • [ 1448-87-9 ]
Reference: [1] Journal of the Chemical Society, 1953, p. 2816,2819
  • 24
  • [ 6935-29-1 ]
  • [ 1448-87-9 ]
  • [ 5448-43-1 ]
  • [ 62163-09-1 ]
  • [ 1196-57-2 ]
Reference: [1] Tetrahedron, 1989, vol. 45, # 24, p. 7795 - 7804
  • 25
  • [ 1448-87-9 ]
  • [ 25554-84-1 ]
  • [ 32601-86-8 ]
Reference: [1] Organic Letters, 2018, vol. 20, # 5, p. 1413 - 1416
  • 26
  • [ 2427-71-6 ]
  • [ 1448-87-9 ]
  • [ 18671-97-1 ]
Reference: [1] Chemistry Letters, 1984, p. 323 - 326
  • 27
  • [ 1448-87-9 ]
  • [ 5182-90-1 ]
Reference: [1] Synlett, 2004, # 13, p. 2323 - 2326
[2] Synlett, 2004, # 13, p. 2323 - 2326
[3] Synlett, 2004, # 13, p. 2323 - 2326
[4] Synlett, 2004, # 13, p. 2323 - 2326
[5] Synlett, 2004, # 13, p. 2323 - 2326
  • 28
  • [ 1448-87-9 ]
  • [ 1865-11-8 ]
Reference: [1] Synlett, 2004, # 13, p. 2323 - 2326
[2] Synlett, 2004, # 13, p. 2323 - 2326
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1448-87-9 ]

Chlorides

Chemical Structure| 2213-63-0

[ 2213-63-0 ]

2,3-Dichloroquinoxaline

Similarity: 0.96

Chemical Structure| 90272-84-7

[ 90272-84-7 ]

2-Chloro-7-methylquinoxaline

Similarity: 0.90

Chemical Structure| 18671-97-1

[ 18671-97-1 ]

2,6-Dichloroquinoxaline

Similarity: 0.87

Chemical Structure| 32601-86-8

[ 32601-86-8 ]

2-Chloro-3-methylquinoxaline

Similarity: 0.87

Chemical Structure| 120258-69-7

[ 120258-69-7 ]

2,8-Dichloroquinoxaline

Similarity: 0.82

Related Parent Nucleus of
[ 1448-87-9 ]

Quinoxalines

Chemical Structure| 2213-63-0

[ 2213-63-0 ]

2,3-Dichloroquinoxaline

Similarity: 0.96

Chemical Structure| 90272-84-7

[ 90272-84-7 ]

2-Chloro-7-methylquinoxaline

Similarity: 0.90

Chemical Structure| 18671-97-1

[ 18671-97-1 ]

2,6-Dichloroquinoxaline

Similarity: 0.87

Chemical Structure| 32601-86-8

[ 32601-86-8 ]

2-Chloro-3-methylquinoxaline

Similarity: 0.87

Chemical Structure| 120258-69-7

[ 120258-69-7 ]

2,8-Dichloroquinoxaline

Similarity: 0.82